This program seeks to foster a synergistic approach to research on mental health issues of HIV infection. Its goal is to encourage the application of multiple scientific perspectives and approaches to stimulate inter- and multidisciplinary collaboration and coordination. NIMH AIDS Research Centers are broadly based investigative endeavors, encompassing or supporting research in a variety of areas, including biological, biomedical, behavioral, neuroscience, prevention, clinical sciences, and services research.
Areas of Emphasis
- Clarify the impact of new biomedical technologies (e.g., microbicides, vaccines, rapid tests, genetic advances) on HIV risk behaviors.
- Foster dissemination, translation, and operational research on ways to implement and enhance long-term maintenance behavior change.
- Promote the global adoption of primary and secondary preventive interventions.
- Identify molecular and cellular mechanisms underlying HIV-associated neurocognitive disorders, and develop therapeutic agents to treat neurologic and neurocognitive complications.
- Identify host and HIV viral genetics that render susceptibility or protection to neuronal dysfunction.
- Identify and characterize HIV-associated cognitive or motor dysfunction and assess it in the context of mental illness and HIV-associated co-morbidities.
Christopher Gordon, Ph.D.
6001 Executive Boulevard, Room 6106, MSC 9619
- HIV Prevention Science Branch
- HIV Treatment and Translational Science Branch
- HIV Neuropathogenesis, Genetics, and Therapeutics Branch
- AIDS Research Centers Program
- Training, Fellowship, and Health Disparities Programs
- Small Business Innovation Research (SBIR) Program and the Small Business Technology Transfer (STTR) Program
- Division of AIDS Research